WallStreetZenWallStreetZen

NASDAQ: UTHR
United Therapeutics Corp Stock Ownership - Who owns United Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have United Therapeutics Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Martine A. RothblattChairperson CEO2025-12-101,000$477.92
$477.92kSell
Martine A. RothblattChairperson CEO2025-12-101,600$480.17
$768.27kSell
Martine A. RothblattChairperson CEO2025-12-10400$480.71
$192.28kSell
Martine A. RothblattChairperson CEO2025-12-101,000$481.72
$481.72kSell
Martine A. RothblattChairperson CEO2025-12-104,000$120.26
$481.04kBuy
Martine A. RothblattChairperson CEO2025-12-094,000$120.26
$481.04kBuy
Martine A. RothblattChairperson CEO2025-12-092,440$477.63
$1.17MSell
Martine A. RothblattChairperson CEO2025-12-091,560$479.33
$747.76kSell
Nilda MesaDirector2025-12-09187$481.63
$90.06kSell
Michael BenkowitzPRESIDENT AND COO2025-12-087,875$478.58
$3.77MSell

1 of 91

UTHR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when UTHR insiders and whales buy or sell their stock.

UTHR Shareholders

What type of owners hold United Therapeutics Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc12.43%5,352,996$2.55BInstitution
Lilly Co Eli12.20%5,251,394$2.50BInsider
Vanguard Group Inc10.26%4,418,610$2.10BInstitution
Renaissance Technologies LLC5.05%2,173,392$1.04BInstitution
Avoro Capital Advisors LLC4.70%2,022,222$963.31MInstitution
State Street Corp4.47%1,922,609$915.85MInstitution
Wellington Management Group LLP3.25%1,398,781$666.32MInstitution
Geode Capital Management LLC2.90%1,249,660$595.29MInstitution
Aqr Capital Management LLC2.29%986,478$469.92MInstitution
Martine A. Rothblatt2.03%872,706$415.72MInsider

1 of 3

UTHR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
UTHR86.64%13.36%Net SellingNet Selling
GMAB96.17%0.00%
RPRX56.76%17.37%Net SellingNet Selling
BNTX20.98%0.00%
INCY77.68%22.32%Net SellingNet Selling
View Top Biotech Stocks

United Therapeutics Stock Ownership FAQ

Who owns United Therapeutics?

United Therapeutics (NASDAQ: UTHR) is owned by 94.92% institutional shareholders, 14.64% United Therapeutics insiders, and 0.00% retail investors. Lilly Co Eli is the largest individual United Therapeutics shareholder, owning 5.25M shares representing 12.20% of the company. Lilly Co Eli's United Therapeutics shares are currently valued at $2.55B.

If you're new to stock investing, here's how to buy United Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.